Genmab A/S Files 6-K Report
Ticker: GNMSF · Form: 6-K · Filed: Jun 18, 2024 · CIK: 1434265
| Field | Detail |
|---|---|
| Company | Genmab A/S (GNMSF) |
| Form Type | 6-K |
| Filed Date | Jun 18, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, sec-filing
TL;DR
Genmab filed a 6-K, nothing major, just standard reporting.
AI Summary
Genmab A/S filed a Form 6-K on June 18, 2024, to report information for the month of June 2024. This filing is incorporated by reference into several of Genmab's S-8 registration statements, including those with file numbers 333-232693, 333-253519, 333-262970, and 333-277273. The company's principal executive offices are located at Carl Jacobsens Vej 30, 2500 Valby, Denmark.
Why It Matters
This filing serves as an update for investors and indicates that Genmab A/S is complying with its reporting obligations under the Securities Exchange Act of 1934.
Risk Assessment
Risk Level: low — This is a routine filing that incorporates previous information into registration statements and does not appear to contain new material financial or operational developments.
Key Players & Entities
- Genmab A/S (company) — Registrant
- 333-232693 (dollar_amount) — S-8 registration statement file number
- 333-253519 (dollar_amount) — S-8 registration statement file number
- 333-262970 (dollar_amount) — S-8 registration statement file number
- 333-277273 (dollar_amount) — S-8 registration statement file number
FAQ
What type of filing is this Form 6-K?
This is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
What is the filing date of this report?
The filing date is June 18, 2024.
What is the period of report for this Form 6-K?
The Conformed Period of Report is June 2024.
Which registration statements does this 6-K filing get incorporated into?
This filing is incorporated by reference into Genmab A/S's registration statements on Form S-8 (File No. 333-232693, 333-253519, 333-262970 and 333-277273).
Where are Genmab A/S's principal executive offices located?
Genmab A/S's principal executive offices are located at Carl Jacobsens Vej 30, 2500 Valby, Denmark.
Filing Stats: 236 words · 1 min read · ~1 pages · Grade level 13.8 · Accepted 2024-06-17 20:26:55
Filing Documents
- tmb-20240617x6k.htm (6-K) — 22KB
- tmb-20240617xex99d1.htm (EX-99.1) — 66KB
- tmb-20240617xex99d1a.htm (EX-99.1(A)) — 28123KB
- tmb-20240617xex99d1001.jpg (GRAPHIC) — 5KB
- tmb-20240617xex99d1a_a001.jpg (GRAPHIC) — 5KB
- tmb-20240617xex99d1a_b001.jpg (GRAPHIC) — 5KB
- 0001558370-24-009261.txt ( ) — 28232KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE MONTH OF JUNE 2024 COMMISSION FILE NUMBER 001-38976 Genmab A/S (Exact name of Registrant as specified in its charter) Carl Jacobsens Vej 30 2500 Valby Denmark +45 70 20 27 28 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F This report on Form 6-K shall be deemed to be incorporated by reference in Genmab A/S's registration statements on Form S-8 (File No. 333-232693, 333-253519, 333-262970 and 333-277273 ) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. nthony GENMAB A/S BY: /s/ Anthony Pagano Name: Anthony Pagano Title: Executive Vice President & Chief Financial Officer DATE: June 18, 2024 EXHIBIT INDEX O Exhibit Description of Exhibit 99.1 Company Announcement Dated June 18, 2024: Transactions in Connection with Share Buy-back Program 99.1(a) Appendix Share buyback program – Specification for June 10 – June 14, 2024